FDA set to authorize Pfizer COVID-19 vaccine for early teens next week, the Times reports

The anticipated approval comes after the drugmakers said in March that the vaccine was found to be safe, effective and produced robust antibody responses in 12- to 15-year-olds in a clinical trial. Israel stands prepared